Moderate carbohydrate diet effects on pregnant women with diabetes
Official title: Effects of Moderate Carbohydrate Consumption on Metabolic and Obstetric Outcomes in Pregnant Women With Insulin-treated Diabetes- A Randomized Controlled Trial
Run by Hadassah Medical Organization · NCT06355154 · Data updated 2026-11-12
This study tests if a moderate carbohydrate diet can help pregnant women with diabetes manage their blood sugar better than the standard diet.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 120 (estimated) |
| Sponsor | Hadassah Medical Organization Academic / other |
| Locations | 1 site (Jerusalem) |
| Status | Recruiting |
| Started | May 28, 2024 |
| Main results expected | May 1, 2027 |
| Study ends | February 1, 2028 |
| Registry record updated | October 2, 2025 |
| Trial ID | NCT06355154 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include pregnant women over 18 years old with singleton pregnancies who are on intensive insulin treatment for diabetes.
✕Probably not a fit
Patients with risk factors for placental insufficiency, hypertension, renal disease, or a history of preeclampsia may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the impact of a moderate carbohydrate diet (≤120g/day) compared to the standard care diet (≥175g/day) on glycemic control and metabolic outcomes in pregnant women with insulin-treated diabetes. The study aims to determine if the moderate carbohydrate approach can improve glycemic balance and alter metabolomic profiles, potentially leading to better pregnancy outcomes. Participants will be monitored using continuous glucose monitoring systems to assess their metabolic responses throughout the trial.
Why it matters
Potential benefit: If successful, this study could lead to improved glycemic control and reduced complications for pregnant women with diabetes.
How similar studies have gone: While some studies have explored carbohydrate restriction during pregnancy, this specific approach is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Pregnant women with singleton pregnancies. * Over 18 years old. * Diagnosis of GDM- 3-h 100-g OGTT according to the American College of Obstetricians and Gynecologists supported by the American Diabetes Association, Or Diagnosis of type 1 or 2 diabetes before pregnancy, Or Diagnosis of early GDM by either OGTT in the first trimester or elevated blood glucose measurements in the fasting (above 95mg/dl) or the postprandial (above 140 mg/dl) state. * Are already on or intended to start intensive insulin treatment (at leased 2 injections of insulin per day) or wear an insulin pump. * Are willing to wear a continuous glucose monitoring system. * BMI of 18.5-42 kg/m2 at the time of diagnosis. Exclusion Criteria: * Individual with risk factors for: * Placental insufficiency. * Hypertension. * Renal disease. * Thrombophilia * Rheumatologic disease. * A history of preeclampsia, or fetal growth restriction (IUGR). * Individuals with a history of preterm labor, or concomitant therapy with β-blockers or glucocorticoids. * Individuals who smoke and/or consume any amount of alcohol during pregnancy.
Where it's running
-
Hadassah Hospital
Jerusalem, Israel Recruiting
Study contacts
- Study coordinator: Genya Aharon Hananel, DR MD PHD
- Email: Genyah@hadassah.org.il
- Phone: 0525576455
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Once-daily long-acting insulin versus long-acting plus mealtime insulin for blood sugar control in pregnancy
This trial will test whether once-daily long-acting insulin alone can control blood sugars as well as long-acting insulin plus mealtime short-acting insulin for pregnant people with gestational or type 2 diabetes.
-
Using hydroxychloroquine to improve pregnancy outcomes in women with Type 2 diabetes
This study is testing if adding hydroxychloroquine to the usual treatment can help pregnant women with Type 2 diabetes have better pregnancy outcomes.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Behavioral toolkit to help pregnant women manage gestational diabetes and pregnancy-related high blood pressure.
This program will test whether a structured behavioral toolkit helps pregnant women with both gestational diabetes and pregnancy-induced high blood pressure better control their blood sugar and blood pressure.
-
Early pregnancy lifestyle patterns and glucose changes in a TOFFFY sub-study
This study tests whether daily patterns like sleep, activity, and meal timing in early pregnancy affect glucose levels and the risk of gestational diabetes, using CGM and wearable data in pregnant women in Singapore.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.